The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review

医学 非酒精性脂肪肝 内科学 荟萃分析 入射(几何) 流行病学 人口 脂肪肝 系统回顾 胃肠病学 人口学 梅德林 疾病 环境卫生 生物 光学 物理 社会学 生物化学
作者
Zobair M. Younossi,Pegah Golabi,James M. Paik,Austin Henry,Catherine Van Dongen,Linda Henry
出处
期刊:Hepatology [Lippincott Williams & Wilkins]
卷期号:77 (4): 1335-1347 被引量:2941
标识
DOI:10.1097/hep.0000000000000004
摘要

BACKGROUND AND AIMS: NAFLD is a leading cause of liver-related morbidity and mortality. We assessed the global and regional prevalence, incidence, and mortality of NAFLD using an in-depth meta-analytic approach. APPROACH AND RESULTS: PubMed and Ovid MEDLINE were searched for NAFLD population-based studies from 1990 to 2019 survey year (last published 2022) per Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Meta-analysis was conducted using random-effects models. Bias risk assessment was per Joanna Briggs Institute. Of 2585 studies reviewed, 92 studies (N=9,361,716) met eligibility criteria. Across the study period (1990-2019), meta-analytic pooling of NAFLD prevalence estimates and ultrasound-defined NAFLD yielded an overall global prevalence of 30.05% (95% CI: 27.88%-32.32%) and 30.69% (28.4-33.09), respectively. Global NAFLD prevalence increased by +50.4% from 25.26% (21.59-29.33) in 1990-2006 to 38.00% (33.71-42.49) in 2016-2019 ( p <0.001); ultrasound-defined NAFLD prevalence increased by +38.7% from 25.16% (19.46-31.87) in 1990-2006 to 34.59% (29.05-40.57) ( p =0.029). The highest NAFLD prevalence was in Latin America 44.37% (30.66%-59.00%), then Middle East and North Africa (MENA) (36.53%, 28.63%-45.22%), South Asia (33.83%, 22.91%-46.79%), South-East Asia (33.07%, 18.99%-51.03%), North America (31.20%, 25.86%-37.08%), East Asia (29.71%, 25.96%-33.76%), Asia Pacific 28.02% (24.69%-31.60%), Western Europe 25.10% (20.55%-30.28%). Among the NAFLD cohort diagnosed without a liver biopsy, pooled mortality rate per 1000 PY was 12.60 (6.68-23.67) for all-cause mortality; 4.20 (1.34-7.05) for cardiac-specific mortality; 2.83 (0.78-4.88) for extrahepatic cancer-specific mortality; and 0.92 (0.00-2.21) for liver-specific mortality. CONCLUSIONS: NAFLD global prevalence is 30% and increasing which requires urgent and comprehensive strategies to raise awareness and address all aspects of NAFLD on local, regional, and global levels.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
qigu完成签到,获得积分10
2秒前
王雪晗发布了新的文献求助10
2秒前
wode发布了新的文献求助30
3秒前
3秒前
4秒前
领导范儿的应助被jianzhong张采纳,获得10
5秒前
若即若离完成签到,获得积分10
5秒前
gebiyouye完成签到 ,获得积分10
6秒前
6秒前
在水一方的应助被类_采纳,获得10
7秒前
ding的应助被哼哼哈嘿采纳,获得10
8秒前
慕青的应助被单纯的盼雁采纳,获得10
8秒前
wode完成签到,获得积分10
8秒前
gebiyouye关注了科研通微信公众号
10秒前
10秒前
li完成签到,获得积分10
11秒前
12秒前
姜忆霜发布了新的文献求助10
14秒前
15秒前
西窗雪完成签到,获得积分10
16秒前
Jack_20708124发布了新的文献求助10
16秒前
飘逸的水壶完成签到,获得积分20
16秒前
16秒前
共享精神的应助被快乐再出发采纳,获得10
16秒前
光亮的书包完成签到,获得积分10
16秒前
小王完成签到,获得积分10
17秒前
柏忆南完成签到 ,获得积分10
18秒前
18秒前
赘婿的应助被hadal采纳,获得30
18秒前
淡定白莲发布了新的文献求助10
20秒前
多情土豆发布了新的文献求助10
21秒前
11111111111111完成签到,获得积分10
22秒前
渡人舟的应助被坚定的白云采纳,获得10
23秒前
aging00完成签到,获得积分10
23秒前
23秒前
26秒前
浅缘一梦完成签到,获得积分10
27秒前
rrr发布了新的文献求助10
28秒前
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Campbell's Operative Orthopaedics, E-Book 3000
Les Mantodea De Guyane 2000
Energie-Contracting 1500
内視鏡下経鼻経蝶形骨洞手術術後SIADHに対する予防的水制限の安全性と有効性の検討 1000
Guidelines for fracture-safe and fatigue-reliable design of steel structures 600
Problems and Solutions for Integer and Combinatorial Optimization: Building Skills in Discrete Optimization 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8016610
求助须知:如何正确求助?哪些是违规求助? 9462536
关于积分的说明 21193791
捐赠科研通 7587577
什么是DOI,文献DOI怎么找? 3385403
关于科研通互助平台的介绍 2518115
邀请新用户注册赠送积分活动 2420515